Home/Vivace Therapeutics/Neelesh Sharma, M.D., Ph.D.
NS

Neelesh Sharma, M.D., Ph.D.

Chief Medical Officer

Vivace Therapeutics

Therapeutic Areas

Vivace Therapeutics Pipeline

DrugIndicationPhase
VT3989Refractory pleural and non-pleural mesothelioma; Advanced solid tumors with NF2 mutationsPhase 1/2